Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
27.9%
% of BBP's 65 holdings also in SBIO
20.0%
% of SBIO's 90 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% | 3.3% | 2.2% |
 |
AXSOME THERAPEUTICS, INC. | 2.1% | 4.5% | 2.1% |
|
PTC THERAPEUTICS INC | 1.8% | 3.6% | 1.8% |
|
MIRUM PHARMACEUTICALS, INC. | 1.7% | 1.9% | 1.7% |
|
ACADIA PHARMACEUTICALS INC | 1.7% | 2.4% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to SBIO
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
GILEAD SCIENCES INC | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
AMGEN INC | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
|
ASCENDIS PHARMA A/S | 1.8% |
BBP Underweight Relative to SBIO
 |
ALKERMES PLC | -4.5% |
|
AVIDITY BIOSCIENCES INC | -3.2% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
 |
MERUS N.V. | -2.7% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.6% |
|
AXSOME THERAPEUTICS, INC. | -2.4% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.2% |
|
DENALI THERAPEUTICS INC. | -1.9% |
|
VERICEL CORPORATION | -1.9% |